Cargando…
The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected Data
Since the first outbreak of Coronavirus Disease-2019 (COVID-19) in January 2020, the medical community has been pursuing effective countermeasures. Early in the pandemic, several small clinical and in vitro studies from France and China reported on the efficacy of chloroquine (CQ) and hydroxychloroq...
Autores principales: | Tang, Wei, Khalili, Leila, Giles, Jon, Gartshteyn, Yevgeniya, Kapoor, Teja, Guo, Cathy, Chen, Tommy, Theodore, Deborah, Askanase, Anca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142615/ https://www.ncbi.nlm.nih.gov/pubmed/34028704 http://dx.doi.org/10.1007/s40744-021-00315-x |
Ejemplares similares
-
Rheumatologists’ perspective on hydroxychloroquine guidelines
por: Winebrake, James, et al.
Publicado: (2020) -
Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients
por: Park, Elizabeth, et al.
Publicado: (2021) -
Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
por: Park, Elizabeth, et al.
Publicado: (2021) -
COVID-19 and systemic lupus erythematosus: a case series
por: Gartshteyn, Yevgeniya, et al.
Publicado: (2020) -
The Use of COVID-19 Vaccines in Patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)